COMMUNIQUÉS West-GlobeNewswire
-
BrewDog and Tilray Beer Are Ready to Pour the World’s Biggest Bar Tab — £1 Million of Free Pints
24/06/2026 -
Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress
24/06/2026 -
Helus Pharma™ Announces US$50 Million Underwritten Offering
24/06/2026 -
RQ Bio Announces $115 Million (£85.5 Million) Series A Financing to Advance Long-Acting Antibody Programme RQB01 for Full Season Influenza Prevention
24/06/2026 -
FEATOL Introduces Anti-Fatigue Mat Designed to Improve Comfort During Long Hours of Standing
24/06/2026 -
MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering
24/06/2026 -
Glass House Brands Provides Notice of Warrant Acceleration
24/06/2026 -
uniQure Announces Pricing of Upsized $225 Million Public Offering
24/06/2026 -
Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn’s Disease
23/06/2026 -
TWL Announces Expanded Online Access to GLP-1 Weight-Loss Care With Insurance and Self-Pay Options
24/06/2026 -
Nyxoah Organisera une Journée Investisseurs à New York le 8 juillet 2026
23/06/2026 -
For the Second Consecutive Year, National Breathe Free Sinus & Allergy Centers Earns Great Place To Work Certification
23/06/2026 -
MSK Masters Announces Release of Sonography of the Extremities - Techniques and Protocols, 5th Edition
23/06/2026 -
Nyxoah to Host Investor Day in New York on July 8, 2026
23/06/2026 -
Zealthy Expands Insurance Coordination for GLP-1 Weight-Loss Medications
23/06/2026 -
Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency
23/06/2026 -
Zealthy Launches Dedicated Tirzepatide Care Pathway for Weight-Management Patients
23/06/2026 -
Zealthy Expands Online Access to Ozempic Evaluations and Insurance Support for Eligible Patients With Type 2 Diabetes
23/06/2026 -
Acquisition of Own Shares
23/06/2026
Pages